The Role of Postoperative Adjuvant Chemotherapy Following Curative Resection for Gastric Cancer: A Meta-Analysis

REFERENCES

• Hunt R. H. Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?. Am. J. Med. 2004; 117: 86S–91S, Suppl 5A
   PubMed Web of Science ®Google Scholar
• Parkin D., Pisani P., Ferlay J. Gobal Cancer Statistics. CA Cancer J. Clin 1999; 49: 33–64
   PubMed Web of Science ®Google Scholar
• Kasakura Y., Phan A., Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg. Oncol. Clin. N. Am. 2002; 11(2)431–444; xii–xiii
   PubMedGoogle Scholar
• Nakajima T. Tabular analysis of 10,000 cases of gastric cancer. Jpn. J. Cancer. Chemother 1994; 21: 1813–1897
   Google Scholar
• Bonenkamp J. J., Hermans J., Sasako M., van de Velde C. J. Extended lymph-node dissection for gastric cancer. N. Engl. J. Med. 1999; 340: 908–914
   PubMed Web of Science ®Google Scholar
• Tan Y. K., Fielding J. W. Early diagnosis of early gastric cancer. Eur J Gastroenterol Hepatol 2006; 18(8)821–829
   PubMed Web of Science ®Google Scholar
• DeVita V. T., Jr., Hellman S., Rosenberg S. A. Cancer. Principles and Practice of Oncology. Lippincott J.B. Co., Philadelphia 1993; 277
   Google Scholar
• Earle C. C., Maroun J., Zuraw L. Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can. J. Surg. 2002; 45(6)438–436
   PubMedGoogle Scholar
• Loutfi A. Therapy for resectable gastric cancer: a practice guideline. Can. J. Surg. 2002; 45(6)410
   PubMed Web of Science ®Google Scholar
• Ohtsu A., Sasako M. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States. Semin. Oncol. 2005; 32: S101–4, (6 Suppl 9)
   PubMed Web of Science ®Google Scholar
• Nitti D., Wils J., Dos Santos J. G., Fountzilas G., Conte P. F., Sava C., et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann. Oncol. 2006; 17: 262–269
   PubMed Web of Science ®Google Scholar
• Bourhis J., Overgaard J., Audry H., Ang K. K., Saunders M., Bernier J., et al. Lancet 2006; 368: 843–854
   PubMed Web of Science ®Google Scholar
• Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Control. Clin. Trials. 1996; 17: 1–12
   PubMedGoogle Scholar
• Felson D. T. Bias in meta-analytic research. J. Clin. Epidemiol. 1992; 45: 885–892
   PubMed Web of Science ®Google Scholar
• Douglass H. O., Stablein D. M., Bruckner H. M., Kabakow B., Storch J., O'Connell M. J., et al. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor. Study. Group. Cancer 1982; 49: 1116–1112
   PubMed Web of Science ®Google Scholar
• Schlag P., Schreml W., Gaus W., Herfarth C., Linder M. M., Queisser W., et al. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results. Recent Results Cancer. Res. 1982; 80: 277–283
   PubMedGoogle Scholar
• Higgins G. A., Amadeo J. H., Smith D. E., Humphrey E. W., Keehn R. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report. Cancer 1983; 52: 1105–1112
   Google Scholar
• Engstrom P. F., Lavin P. T., Douglass H. O., Jr., Brunner K. W. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275). Cancer 1985; 55: 1868–1873
   PubMed Web of Science ®Google Scholar
• Bonfanti G., Gennari L., Bozzette F., Luporini G., Valagussa P., Mezzanotte G., et al. Adjuvant treatments following curative resection for gastric cancer. The Italian Gastroinstinal Tumor Study Group. Br. J. Surg. 1988; 75: 1100–1104
   PubMed Web of Science ®Google Scholar
• Coombes R. C., Schein P. S., Chilvers C. E., Wils J., Beretta G., Bliss J. M., et al. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J. Clin. Oncol. 1990; 8: 1362–1369
   PubMed Web of Science ®Google Scholar
• Krook J. E., O'Connell M. J., Wieand H. S., Beart R. W., Jr., Leigh J. E., Kugler J. W., et al. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer 1991; 67: 2454–2458
   PubMed Web of Science ®Google Scholar
• Lise M., Nitti D., Marchet A., Sahmoud T., Buyse M., Duez N., et al. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J. Clin. Oncol. 1995; 13: 2757–2763
   PubMed Web of Science ®Google Scholar
• Macdonald J. S., Fleming T. R., Peterson R. F., Berenberg J. L., McClure S., Chapman R. A., et al. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann. Surg. Oncol. 1995; 2: 488–494
   PubMed Web of Science ®Google Scholar
• Cirera L., Balil A., Batiste-Alentorn E., Tusquets I., Cardona T., Arcusa A., et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J. Clin. Oncol. 1999; 17: 3810–3815
   PubMed Web of Science ®Google Scholar
• Nakajima T., Nashimoto A., Kitamura M., Kito T., Iwanaga T., Okabaybshi K. Adjuvant mitonycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Lancet. 1999; 354: 273–277
   PubMed Web of Science ®Google Scholar
• Tsavaris N., Tentas K., Kosmidis P., Mylonakis N., Sakelaropoulos N., Kosmas C., et al. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy 1996; 42: 220–226
   PubMed Web of Science ®Google Scholar
• Neri B., Cini G., Andreoli F., Boffi B., Francesconi D., Mazzanti R., et al. Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br. J. Cancer 2001; 84: 878–880
   PubMed Web of Science ®Google Scholar
• Bajetta E., Buzzoni R., Mariani L., Beretta E., Bozzetti F., Bordogna G., et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian. Ann. Oncol. 2002; 13: 299–307
   PubMed Web of Science ®Google Scholar
• Nashimoto A., Nakajima T., Furukawa H., Kitamura M., Kinoshita T., Yamamura Y., et al. Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206-1. J. Clin. Oncol. 2003; 21: 2282–2287
   PubMed Web of Science ®Google Scholar
• Chipponi J., Huguier M., Pezet D., Basso N., Hay J. M., Quandalle P., et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Am. J. Surg. 2004; 187: 440–445
   PubMed Web of Science ®Google Scholar
• Bouche O., Ychou M., Burtin P., Bedenne L., Ducreux M., Lebreton G., et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann. Oncol. 2005; 16: 1488–1497
   PubMed Web of Science ®Google Scholar
• Mari E., Floriani I., Tinazzi A., Buda A., Belfiglio M., Valentini M., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the ISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann. Oncol. 2000; 11: 837–843
   PubMed Web of Science ®Google Scholar
• Huguier M., Destroyes J. P., Baschet C., Le Henand F., Bernard P. F. Gastric carcinoma treated by chemotherapy after resection: a controlled study. Am. J. Surg. 1980; 139: 197–199
   PubMed Web of Science ®Google Scholar
• Nakajima T., Takahashi T., Takagi K., Kuno K., Kajitani T. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J. Clin. Oncol. 1984; 2: 1366–137
   PubMed Web of Science ®Google Scholar
• Allum W. H., Hallissey M. T., Kelly K. A. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet 1989; 1: 571–574
   PubMed Web of Science ®Google Scholar
• Allum W. H., Hallissey M. T., Ward L. C., Hockey M. S. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. Br. J. Cancer 1989; 60: 739–744
   PubMed Web of Science ®Google Scholar
• Kim J. P., Kwon O. J., Oh S. T., Yang H. K. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann. Surg. 1992; 216: 269–279
   PubMed Web of Science ®Google Scholar
• Grau J. J., Estape J., Alcobendas F., Pera C., Daniels M., Teres J. Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients. Eur. J. Cancer 1993; 29: 340–342
   Google Scholar
• Hallissey M. T., Dunn J. A., Ward L. C., Allum W. H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994; 343: 1309–1312
   PubMed Web of Science ®Google Scholar
• Neri B., de Leonardis V., Romano S., Andreoli F., Pernice L. M., Bruno L., et al. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br. J. Cancer 1996; 73: 549–552
   PubMed Web of Science ®Google Scholar
• Macdonald J. S., Smalley S. R., Benedetti J., Hundahl S. A., Estes N. C., Stemmermann G. N., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med. 2001; 345(10)725–30
   PubMed Web of Science ®Google Scholar
• Cunningham D., Allum W. H., Stenning S. P., Thompson J. N., Van de Velde C. J., Nicolson M., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 2006; 355(1)11–20
   PubMed Web of Science ®Google Scholar
• Serlin O., Wolkoff J. S., Amadeo J. M., Keehn R. J. Use of 5-fluorodeoxyuridine(FUDR) as an adjuvant to the surgical management of carcinoma of the stomach. Cancer 1969; 24: 223–228
   PubMed Web of Science ®Google Scholar
• Kelsen D. P. Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol. Jun, 1996; 23(3)379–89
   PubMed Web of Science ®Google Scholar
• Douglas H. O. Gastric cancer:Overview of current therapies. Semin. Oncol. 1985; 12: 57–62
   PubMed Web of Science ®Google Scholar
• Boku T., Nakane Y., Okusa T., Hirozane N., Imabayashi N., Hioki K., et al. Strategy for lymphadenectomy of gastric cancer. Surgery 1989; 105: 585–592
   PubMed Web of Science ®Google Scholar
• Nakamura K., Ueyama T., Yao T., Xuan Z. X., Ambe K., Adachi Y., et al. Pathology and prognosis of gastric carcinoma:Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992; 70: 1030–1037
   PubMed Web of Science ®Google Scholar
• Sawai K., Takahashi T., Suzuki H. New trends in surgery for gastric cancer in Japan. J Surg Oncol. 1994; 56: 221–226
   PubMed Web of Science ®Google Scholar
• Ross P., Norman A., Cunningham D., Webb A., Iveson T., Padhani A., et al. A prospective randomized trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann. Oncol. 1997; 8: 995–1001
   PubMed Web of Science ®Google Scholar
• Estape J., Grau J. J., Lcobendas F., Curto J., Daniels M., Viñolas N., et al. Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up. Ann. Surg. 1991; 213: 219–221
   PubMed Web of Science ®Google Scholar
• Grau J. J., Estapé J., Alcobendas F., Pera C., Daniels M., Terés J. Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients. Eur. J. Cancer 1993; 29A: 340–342
   PubMed Web of Science ®Google Scholar
• Grau J. J., Estapé J., Fuster J., Filella X., Visa J., Terés J., et al. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer. J. Clin. Oncol. 1998; 16: 1036–1039
   PubMed Web of Science ®Google Scholar
• Cirera L., Balil A., Batiste-Alentorn E., Tusquets I., Cardona T., Arcusa A., et al. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer. J. Clin. Oncol. 1999; 17: 3810–3815
   PubMed Web of Science ®Google Scholar
• Allum W. H., Hallissey M. T., Kelly K. A. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet 1989; 1: 571–574
   PubMed Web of Science ®Google Scholar
• Hermans J., Bonenkamp J. J., Boon M. C., Bunt A. M., Ohyama S., Sasako M., et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J. Clin. Oncol. 1993; 11: 1441–1447
   PubMed Web of Science ®Google Scholar
• Earle C. C., Maroun J. A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur. J. Cancer 1999; 35: 1059–1064
   PubMed Web of Science ®Google Scholar
• Panzini I., Gianni L., Fattori P. P., Tassinari D., Imola M., Fabbri P., et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002; 88: 21–27
   PubMed Web of Science ®Google Scholar
• Hu J. K., Chen Z. X., Zhou Z. G., Zhang B., Tian J., Chen J. P., et al. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J. Gastroenterol 2002; 8: 1023–1028
   PubMed Web of Science ®Google Scholar
• Janunger K. G., Hafstrom L., Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur. J. Surg. 2002; 168: 597–608
   PubMedGoogle Scholar